0.80USD
45.91 MUSD
136.16 MUSD
57.15 M
About Protect Pharmaceutical Corp
Protect Pharmaceutical Corp. is a drug delivery and new product development company. It develops clinically effective drugs and is building a robust pipeline of product candidates based on its proprietary technologies, scientific knowledge, and clinical expertise. The company was founded on August 5, 1987 and is headquartered in Draper, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PRTT is 2.70 USD — it has decreased by 3.91% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Protect Pharmaceutical Corp stocks are traded under the ticker PRTT.
PRTT stock is 11.26% volatile and has beta coefficient of −0.23. Check out the list of the most volatile stocks — is Protect Pharmaceutical Corp there?
Yes, you can track Protect Pharmaceutical Corp financials in yearly and quarterly reports right on TradingView.
PRTT stock has fallen by 6.25% compared to the previous week, the month change is a 12.50% rise, over the last year Protect Pharmaceutical Corp has showed a 241.77% increase.
PRTT net income for the last quarter is 14.16 M USD, while the quarter before that showed 23.19 M USD of net income which accounts for −38.92% change. Track more Protect Pharmaceutical Corp financial stats to get the full picture.
No, PRTT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRTT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Protect Pharmaceutical Corp stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Protect Pharmaceutical Corp technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Protect Pharmaceutical Corp stock shows the buy signal. See more of Protect Pharmaceutical Corp technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Protect Pharmaceutical Corp EBITDA is 47.54 M USD, and current EBITDA margin is 34.92%. See more stats in Protect Pharmaceutical Corp financial statements.